{"id":"W2884362356","doi":"10.1038/s41375-018-0210-1","title":"Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":247,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Servier; Astex Pharmaceuticals; Astellas Pharma; Gilead Sciences; Ablynx; Teva Pharmaceutical Industries; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Internal medicine; Tolerability; Gastroenterology; Peripheral edema; Nausea; Discontinuation; Adverse effect; Refractory (planetary science); Minimal residual disease; Progressive disease; Leukemia; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003461013,0.0003579937,0.0004242821,0.0002412001,0.0002537864,0.00002847784,0.0005398818,0.0006672259,0.002384001],"category_scores_gemma":[0.00007059163,0.0003402382,0.0001422067,0.0003041813,0.0003413794,0.000162293,0.0001949099,0.0009002268,0.007163777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001067268,"about_ca_system_score_gemma":0.0005767366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007174623,"about_ca_topic_score_gemma":0.0003652021,"domain_scores_codex":[0.9977819,0.0002025438,0.0005329463,0.0005958413,0.00007195336,0.00081483],"domain_scores_gemma":[0.9988539,0.0001029715,0.0001750478,0.0007463582,0.00007162856,0.00005006626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002347457,0.0001237029,0.0008300125,0.00002309444,0.00003875637,0.0000476186,0.000888514,0.00001017855,0.9693164,0.00113375,0.02069375,0.00665951],"study_design_scores_gemma":[0.005524439,0.0009039047,0.01145625,0.00009342743,0.00003198289,0.00007274825,0.0004975153,0.00007210775,0.6992726,0.0009529518,0.2804376,0.0006844208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9648455,0.001736791,0.000189782,0.00007125736,0.002350972,0.0003377992,0.00002320837,0.0002066901,0.03023797],"genre_scores_gemma":[0.9791107,0.00008056883,0.0004876206,0.0007230089,0.0001815934,0.00004991251,0.00005373853,0.00005901741,0.01925387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2700437,"threshold_uncertainty_score":0.999905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009278922816624076,"score_gpt":0.2184857901486672,"score_spread":0.2092068673320432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}